MedPath

A Multicenter, randomized, parallel-group study assessing efficacy of actual support of renal replacement therapy modality selection program(CKD-SMD app) and home blood pressure measurement system in patients with chronic kidney disease(CKD)

Not Applicable
Conditions
Patients with chronic kidney disease(CKD)
Registration Number
JPRN-UMIN000025792
Lead Sponsor
Department of Sophia University
Brief Summary

All participants baseline data were the mean (SD) age, eGFR, and HBPM (morning and evening) of participants were 70.7(11.0) years, 37.0ml/min per 1.73 m2, and 133.7/78.3 and 130.5/76.0mmHg, respectively. No significant differences between groups were observed at baseline. In the female intervention group, the morning systolic blood pressure (SBP) difference significantly decreased, -7.7 vs. -2.6 mmHg (p<0.05).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
54
Inclusion Criteria

Not provided

Exclusion Criteria

Investigator or investigator be inappropriate as determined. After renal transplantation. they are likely to introduce renal replacement therapy within one month. Minor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath